BriaCell Therapeutics Corp. (OTCMKTS:BCTXF – Get Free Report)’s share price traded up 2.1% during mid-day trading on Monday . The company traded as high as $0.89 and last traded at $0.89. 508,175 shares traded hands during trading, an increase of 27,236% from the average session volume of 1,859 shares. The stock had previously closed at $0.87.
BriaCell Therapeutics Trading Down 7.5 %
The company’s fifty day simple moving average is $0.80 and its 200 day simple moving average is $1.15. The firm has a market capitalization of $594,362.80, a P/E ratio of -0.20 and a beta of 1.09.
About BriaCell Therapeutics
BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.
Further Reading
- Five stocks we like better than BriaCell Therapeutics
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- How to Invest in Blue Chip Stocks
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
